IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification

Go back to IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification
(NASDAQ: IMNN) Delayed: 1.66 +0.07 (4.40%)
Previous Close $1.59    52 Week High
Open $1.60    52 Week Low
Day High $1.68    P/E N/A 
Day Low $1.53    EPS
Volume 156,329